Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Chloroquine

- PMLiVE

Lilly halts most clinical trials as coronavirus disruption continues

Will continue ongoing trials for patients who are already enrolled

- PMLiVE

FDA green lights rapid coronavirus diagnostic test

Test can diagnose positive cases in approximately 45 minutes

- PMLiVE

Gilead halts individual requests for COVID-19 hopeful remdesivir

Will now focus on expanded access programmes and backlog

- PMLiVE

WHO partners with WhatsApp to provide accurate COVID-19 information

Social media platform will provide users with facts around virus

- PMLiVE

UK, China prep trials of coronavirus vaccine candidates

UK vaccine clinical trials set to begin next month

Novartis day

Novartis donates malaria drug for COVID-19 clinical trials

Hydroxychloroquine will be evaluated for efficacy against novel coronavirus disease

- PMLiVE

LifeArc creates £10m COVID-19 research fund

Medical research charity joins efforts against coronavirus

- PMLiVE

FDA maintains COVID-19 therapeutics must meet a ‘gold standard’

Comes after President Trump called for expedited approval of potential treatments

- PMLiVE

Trump calls on FDA to cut ‘red tape’ as coronavirus drug trials gather pace

A number of candidates begin trial testing

- PMLiVE

Germany’s coronavirus infections climb but deaths remain low

Experts debate ‘anomaly’ as other countries record higher death rates

- PMLiVE

EMA calls for pooled EU research into COVID-19 therapies

Asks for a harmonised methodology across member states

- PMLiVE

Lilly partners with Indiana State Health Department for coronavirus testing

Experts maintain that testing can curb the outbreak

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links